DE69422928D1 - Modifizierte maxadilan-protein, dessen herstellung und verwendung, und dem protein kodierende dns - Google Patents

Modifizierte maxadilan-protein, dessen herstellung und verwendung, und dem protein kodierende dns

Info

Publication number
DE69422928D1
DE69422928D1 DE69422928T DE69422928T DE69422928D1 DE 69422928 D1 DE69422928 D1 DE 69422928D1 DE 69422928 T DE69422928 T DE 69422928T DE 69422928 T DE69422928 T DE 69422928T DE 69422928 D1 DE69422928 D1 DE 69422928D1
Authority
DE
Germany
Prior art keywords
protein
production
dna encoding
modified maxadilan
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69422928T
Other languages
English (en)
Other versions
DE69422928T2 (de
Inventor
Masahiro Tajima
Manami Ohnuma
L Lerner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
General Hospital Corp
Original Assignee
Shiseido Co Ltd
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd, General Hospital Corp filed Critical Shiseido Co Ltd
Publication of DE69422928D1 publication Critical patent/DE69422928D1/de
Application granted granted Critical
Publication of DE69422928T2 publication Critical patent/DE69422928T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43577Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69422928T 1993-08-06 1994-08-05 Modifizierte maxadilan-protein, dessen herstellung und verwendung, und dem protein kodierende dns Expired - Fee Related DE69422928T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/102,757 US5480864A (en) 1993-08-06 1993-08-06 Modified maxadilan protein, its preparation and use, and DNA encoding the protein
PCT/US1994/008809 WO1995004829A1 (en) 1993-08-06 1994-08-05 Modified maxadilan protein, its preparation and use, and dna encoding the protein

Publications (2)

Publication Number Publication Date
DE69422928D1 true DE69422928D1 (de) 2000-03-09
DE69422928T2 DE69422928T2 (de) 2000-06-29

Family

ID=22291533

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69422928T Expired - Fee Related DE69422928T2 (de) 1993-08-06 1994-08-05 Modifizierte maxadilan-protein, dessen herstellung und verwendung, und dem protein kodierende dns

Country Status (7)

Country Link
US (1) US5480864A (de)
EP (1) EP0713532B1 (de)
JP (1) JPH09504423A (de)
AU (1) AU678515B2 (de)
CA (1) CA2167489A1 (de)
DE (1) DE69422928T2 (de)
WO (1) WO1995004829A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397772A (en) * 1989-06-29 1995-03-14 The President And Fellows Of Harvard College Vasodilatory peptides from the salivary gland of the sand fly Lutzomyia longipalpis
US6462016B1 (en) * 1995-10-06 2002-10-08 Shiseido Company, Ltd. Method for screening agonist or antagonist of the maxadilan receptor participating in vasodilating action, and compound found by the method
US6017533A (en) * 1996-04-25 2000-01-25 Shiseido Company, Ltd. Peptides having specific affinity to pituitary adenylate cyclase activating polypeptide type 1 receptors
US6162785A (en) 1997-03-13 2000-12-19 Auburn University Recombinant vasoactive protein from salivary gland of the black fly
US20030109447A1 (en) * 1997-03-13 2003-06-12 Auburn University Methods of use of recombinant vasoactive protein from salivary gland of the black fly
US7211652B2 (en) * 2003-11-25 2007-05-01 Auburn University Protein from horn fly saliva that disrupts hemostasis
US20090130130A1 (en) * 2005-06-10 2009-05-21 National University Of Singapore Mutant allergen(s)
CN101626894B (zh) * 2007-01-08 2013-09-11 尤尼弗瑞克斯I有限责任公司 阻火薄膜层压材料
CN101125882B (zh) * 2007-07-20 2010-10-13 暨南大学 重组pac1受体激动剂rmmax及其表达方法与应用
MX2019008056A (es) 2017-01-05 2019-11-21 Univ California Agonistas del receptor pac1 (maxcaps) y usos de estos.
AR111842A1 (es) 2017-06-02 2019-08-21 Amgen Inc Antagonistas de péptido pac1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ224663A (en) * 1987-05-28 1990-11-27 Amrad Corp Ltd Fusion proteins containing glutathione-s-transferase and expression of foreign polypeptides using glutathione-s-transferase encoding vectors
CA2063260A1 (en) * 1989-06-29 1990-12-30 Ethan A. Lerner Vasodilatory and immune suppressant peptides

Also Published As

Publication number Publication date
US5480864A (en) 1996-01-02
EP0713532A1 (de) 1996-05-29
WO1995004829A1 (en) 1995-02-16
EP0713532B1 (de) 2000-02-02
DE69422928T2 (de) 2000-06-29
CA2167489A1 (en) 1995-02-16
JPH09504423A (ja) 1997-05-06
AU678515B2 (en) 1997-05-29
AU7451494A (en) 1995-02-28

Similar Documents

Publication Publication Date Title
DE68924026D1 (de) Biosensor und dessen herstellung.
ATE184708T1 (de) Polysiloxan-polyol makromere, deren herstellung und verwendung
DE69529026D1 (de) Trehalose, ihre Herstellung und ihre Verwendung
DE69422410T2 (de) Polymerisationskataylsatoren, ihre herstellung und verwendung
AU1235392A (en) Cytokine-induced protein, tsg-14, dna coding therefor and uses thereof
DE68903512D1 (de) Korrosionshemmendes pigment und dessen herstellung.
ATE239693T1 (de) 3,3-diarylpropylamine , ihre verwendung und herstellung
AU4224889A (en) Synthetic, anti-complement protein and the gene encoding same
EP0736034A4 (de) Den wnt-x wachstumsfaktor kodierende dns
ATE114680T1 (de) Lufttrocknende polyurethanharze, deren herstellung und verwendung.
DE59800590D1 (de) Polymere organosiliciumverbindungen, deren herstellung und verwendung
AU6550894A (en) Human serotonin receptors, dna encoding the receptors, and uses thereof
DE69422928D1 (de) Modifizierte maxadilan-protein, dessen herstellung und verwendung, und dem protein kodierende dns
DE59409541D1 (de) Bicyclen-derivate, ihre herstellung und verwendung
DE69532485D1 (de) Trehalose-freisetzendes Enzym, dafür kodierende DNA, Herstellung und Verwendung
DE69413183T2 (de) Indazolsulfonylharnstoff-derivat, verwendung und zwischenprodukte zur herstellung
DE69031606D1 (de) Kern-Schale-Polymer, Herstellung und dessen Verwendung
DE69617453D1 (de) Neuartiger photokatalysator, seine herstellung und methode zur wasserstoffproduktion mit demselben
DE58908788D1 (de) Modifizierte Blockpolymerisate, ihre Herstellung und Verwendung.
DE59606806D1 (de) Polymerholz-formkörper, ihre herstellung und verwendung
DE68917154D1 (de) C-terminus-amidierungsenzym-zusammensetzung, verfahren zur herstellung und verwendung.
DE1039889T1 (de) Immunoglobulinreiche milch, dessen herstellung und verwendung
ITRM930502A0 (it) Procedimento per la produzione di r amminocarnitina e s amminocarnitina.
ATE321772T1 (de) Echinocandinderivate, deren herstellung und deren verwendung zur bekämpfung von pilzen
DE3667473D1 (de) Ganz oder teilweise mit epsilon-caprolactam blockiertes trans-cyclohexan-1,4-diisocyanat, dessen herstellung und verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee